These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells. Damirin A; Tomura H; Komachi M; Tobo M; Sato K; Mogi C; Nochi H; Tamoto K; Okajima F Mol Pharmacol; 2005 Apr; 67(4):1177-85. PubMed ID: 15625281 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function. Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300 [TBL] [Abstract][Full Text] [Related]
13. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942 [TBL] [Abstract][Full Text] [Related]
14. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Negre-Salvayre A; Dousset N; Ferretti G; Bacchetti T; Curatola G; Salvayre R Free Radic Biol Med; 2006 Oct; 41(7):1031-40. PubMed ID: 16962927 [TBL] [Abstract][Full Text] [Related]
15. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. Bühler FR; Tkachuk VA; Hahn AW; Resink TJ J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968 [TBL] [Abstract][Full Text] [Related]
16. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912 [TBL] [Abstract][Full Text] [Related]
17. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Frias MA; James RW; Gerber-Wicht C; Lang U Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362 [TBL] [Abstract][Full Text] [Related]
18. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230 [TBL] [Abstract][Full Text] [Related]
19. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). Potì F; Simoni M; Nofer JR Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400 [TBL] [Abstract][Full Text] [Related]
20. Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins. Tölle M; Schuchardt M; van der Giet M Curr Pharm Des; 2010 May; 16(13):1468-79. PubMed ID: 20196741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]